Central Drugs Standard Control Organisation Cdsco
- All
- News
- Videos
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Covid Vaccines Have Many Side-Effects? Centre Calls It "Erroneous Claim"
The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Drug Firm Hetero Gets Approval To Produce, Sell Sputnik Light Vaccine
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
CBI Arrests Two Top Drug Regulator Officers For Taking Rs 3.5 Lakh Bribe
The CBI has arrested two officers of the Central Drugs Standard Control Organisation (CDSCO) at Ahmedabad for allegedly taking a bribe of Rs 3.50 lakh from a person who is into medical device manufacturing, the probe agency said on Sunday.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Drugs Control Organisation Issues COVID-19 Vaccines' Trial, Marketing Guidelines
The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 2019.
-
Top Drug Regulator Suspends Mumbai-Based Firm's Import License For COVID Kit: Report
The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
-
Lupin Gets Drug Regulator's Nod For Indigestion Treatment Tablets
Drug firm Lupin has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Acotiamide 100 mg tablets used for treatment of indigestion.
-
Sanofi Recalls Some Batches Of Painkiller Combiflam In India
India's Central Drugs Standard Control Organisation (CDSCO) said in notices posted on its website in February and April that it had found some batches of Combiflam to be "not of standard quality" as they failed disintegration tests.
-
Ranbaxy gets regulator nod to sell malaria drug 'SynriamTM'
The company has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market SynriamTM in India for the treatment of uncomplicated malaria in adults caused by Plasmodium vivax parasite, Ranbaxy Laboratories Ltd said in a statement.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
-
Probe shows serious problems with India's drug regulator
A new Parliamentary report claims India's main drug regulator has not been properly scrutinising some drugs, and some officials are circumventing procedure.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Covid Vaccines Have Many Side-Effects? Centre Calls It "Erroneous Claim"
The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Drug Firm Hetero Gets Approval To Produce, Sell Sputnik Light Vaccine
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
CBI Arrests Two Top Drug Regulator Officers For Taking Rs 3.5 Lakh Bribe
The CBI has arrested two officers of the Central Drugs Standard Control Organisation (CDSCO) at Ahmedabad for allegedly taking a bribe of Rs 3.50 lakh from a person who is into medical device manufacturing, the probe agency said on Sunday.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Drugs Control Organisation Issues COVID-19 Vaccines' Trial, Marketing Guidelines
The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 2019.
-
Top Drug Regulator Suspends Mumbai-Based Firm's Import License For COVID Kit: Report
The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
-
Lupin Gets Drug Regulator's Nod For Indigestion Treatment Tablets
Drug firm Lupin has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Acotiamide 100 mg tablets used for treatment of indigestion.
-
Sanofi Recalls Some Batches Of Painkiller Combiflam In India
India's Central Drugs Standard Control Organisation (CDSCO) said in notices posted on its website in February and April that it had found some batches of Combiflam to be "not of standard quality" as they failed disintegration tests.
-
Ranbaxy gets regulator nod to sell malaria drug 'SynriamTM'
The company has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market SynriamTM in India for the treatment of uncomplicated malaria in adults caused by Plasmodium vivax parasite, Ranbaxy Laboratories Ltd said in a statement.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
-
Probe shows serious problems with India's drug regulator
A new Parliamentary report claims India's main drug regulator has not been properly scrutinising some drugs, and some officials are circumventing procedure.
